PV Bulletin

Low Flu Vaccination Rates Among Primary School Children

Only 55.5% of eligible primary school children received their flu vaccine last winter.

Primary source: Open Government Licence v3.0

PV Impact Brief

Urgency: HighConfidence: high

What changed

The UKHSA has initiated a campaign reminding parents to return consent forms for flu vaccinations, with local immunisation teams visiting schools to ensure eligible children are vaccinated before flu peaks in December and January.

Why it matters

Tracking vaccination rates and ensuring high uptake is crucial for public health, as flu can lead to serious complications in younger children. Lower vaccination rates could lead to increased hospitalizations and impact children’s health and education.

Action needed

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Relevant for
PV Quality LeadMedical Safety Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 7, 2026

Full briefing

Practical implication

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

The UK Health Security Agency (UKHSA) reported that during the 2025-26 flu season, just 55.5% of primary school children received their vaccine, highlighting a decline from pre-pandemic rates. The UKHSA emphasizes the importance of returning flu consent forms to ensure children are vaccinated during the upcoming school vaccination sessions, which will roll out across schools starting this week, with completion expected by late November.

What changed: The UKHSA has initiated a campaign reminding parents to return consent forms for flu vaccinations, with local immunisation teams visiting schools to ensure eligible children are vaccinated before flu peaks in December and January.

Why it matters: Tracking vaccination rates and ensuring high uptake is crucial for public health, as flu can lead to serious complications in younger children. Lower vaccination rates could lead to increased hospitalizations and impact children’s health and education.

Practical implication: Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

View original source

  • Source: MHRA - News and communications
  • Published at source: 2026-09-07T00:00:00.000Z
  • Discovered by monitor: 2026-09-07T21:56:47.621Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Atellica CH Revised C-Reactive Protein (RCRP) Safety Information - Siemens Healthcare Diagnostics

Urgency: High

Laboratories must implement the safety measures as indicated by the action registration number R2625739, effective from the notice date of September 7, 2026.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward